Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683
C. Le Pechoux et al.
ANNALS OF ONCOLOGY (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy
Wenhui Wang et al.
BMC CANCER (2019)
A Prospective Randomized Phase III Study of Precise PORT for Patients with pIIIA-N2 NSCLC After Complete Resection and Adjuvant Chemotherapy
Z. Hui et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer
Justin A. Drake et al.
ANNALS OF THORACIC SURGERY (2018)
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong et al.
LANCET ONCOLOGY (2018)
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database
Alex Herskovic et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
Valerie W. Rusch et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Postoperative Radiotherapy is Associated with Better Survival in Non-Small Cell Lung Cancer with Involved N2 Lymph Nodes Results of an Analysis of the National Cancer Data Base
John L. Mikell et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non-Small-Cell Lung Cancer Using the National Cancer Database
Christopher D. Corso et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Role of Postoperative Radiotherapy After Curative Resection and Adjuvant Chemotherapy for Patients With Pathological Stage N2 Non-Small-Cell Lung Cancer: A Propensity Score Matching Analysis
Byoung Hyuck Kim et al.
CLINICAL LUNG CANCER (2014)
Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial
Wen-yi Shen et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Management of Stage IIIA Non-Small Cell Lung Cancer by Thoracic Surgeons in North America
Nirmal K. Veeramachaneni et al.
ANNALS OF THORACIC SURGERY (2012)
A MULTICENTER RETROSPECTIVE ANALYSIS OF SURVIVAL OUTCOME FOLLOWING POSTOPERATIVE CHEMORADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH N2 NODAL DISEASE
Bingwen Zou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Impact of postoperative radiation therapy on survival in patients with complete resection and Stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The Adjuvant Navelbine International Trialist Association (ANITA) randomized trial
Jean-Yves Douillard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database
Brian E. Lally et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
T Le Chevalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
